Biospecifics Technologies Corp (NASDAQ:BSTC)

56.23
Delayed Data
As of Aug 23
 -1.38 / -2.40%
Today’s Change
48.68
Today|||52-Week Range
73.31
-7.21%
Year-to-Date
No recent news for Biospecifics Technologies Corp.

Today’s Trading

Previous close57.61
Today’s open57.57
Day’s range55.94 - 57.96
Volume38,961
Average volume (3 months)65,776
Market cap$430.5M
Data as of 4:00pm ET, 08/23/2019

Growth & Valuation

Earnings growth (last year)+75.25%
Earnings growth (this year)+16.12%
Earnings growth (next 5 years)+38.00%
Revenue growth (last year)+20.11%
P/E ratio18.7
Price/Sales13.48
Price/Book4.40

Competitors

 Today’s
change
Today’s
% change
EOLSEvolus Inc-0.59-3.79%
CRNXCrinetics Pharmaceut...-0.84-4.74%
DOVADova Pharmaceuticals...-0.62-4.10%
TCRRTCR2 Therapeutics In...+1.01+6.38%
Data as of 4:15pm ET, 08/23/2019

Financials

Next reporting dateNovember 8, 2019
EPS forecast (this quarter)$0.75
Annual revenue (last year)$33.0M
Annual profit (last year)$20.1M
Net profit margin60.84%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer
Ronald Law
Chief Financial Officer
Patrick M. Caldwell
Corporate headquarters
Lynbrook, New York

Forecasts